Next Article in Journal
Combined Effect of Green Tea Extract and Vitamin E on Serum and Heart Tissue Lipids, Lipid Metabolizing Enzymes and Histopathological Alteration in Isoproterenol-Induced Myocardial Infarction in Rats
Previous Article in Journal
Synthesis of Tetrahydrobenzothieno[ 2,3-d]pyrimidine and Tetrahydrobenzothieno[3,2-e]- [1,2,4]triazolo[4,3-c]pyrimidine Derivatives as Potential Antimicrobial Agents
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Structural Studies of an Impurity Obtained During the Synthesis of Telithromycin Derivatives

by
Nirmala MUNIGELA
1,*,
Moses BABU J.
1,
Anjaneyulu YERRAMILLI
2,
Gurpreet SINGH
3,
Bhaskar REDDY
3,
Mohamed TAKHI
3,
Lakshmi Kumar TATINI
1,
Sreekanth BUKKAPATTANAM R.
1 and
Peddy VISHWESHWAR
1
1
Department of Analytical Research, Discovery Research, Dr. Reddy’s Laboratories Ltd., Miyapur, Hyderabad 500049, India
2
Institute of Science and Technology, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad, 500 072, India
3
Department of Chemistry, Discovery Research, Dr. Reddy’s Laboratories Ltd., Miyapur, Hyderabad 500049, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(4), 775-790; https://doi.org/10.3797/scipharm.0907-01
Submission received: 3 July 2009 / Accepted: 27 August 2009 / Published: 28 August 2009

Abstract

In an effort to synthesize a key intermediate, for synthesis of a variety of telithromycin derivatives a new by-product has been formed at the third stage of the synthetic scheme. The starting material, Clarithromycin, on treatment with hydrochloric acid and on benzoylation resulted in the formation of (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-4,12,13-trihydroxy-7-methoxy- 3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl 3,4,6-trideoxy- 3-(dimethylamino)-2-O-(phenylcarbonyl)-β-D-xylo-hexopyranoside (2). Oxidation of this gave (3R,5R,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy- 7-methoxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxooxacyclotetradecan-6-yl 3,4,6-trideoxy-3-(dimethylamino)-2-O-(phenylcarbonyl)-β-D-xylo-hexopyranoside (3), and also an unexpected by-product 4 in equivalent amounts. The O21–H hydroxyl group in 3 was mesylated with dimethyl sulphoxide (DMSO) in pyridine leading to the precursor (3R,5R,6R,7R,9R,11R,12R,13S,14R)-14-ethyl- 12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-12-(methylsulfinyl)- 2,4,10-trioxooxacyclotetradecan-6-yl 3,4,6-trideoxy-3-(dimethylamino)-2-O- (phenylcarbonyl)-β-D-xylo-hexopyranoside (5), which on further treatment with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in acetone and methylene chloride resulted in the formation of intermediate 6. The by-product 4 and the intermediate 6 were isolated and characterized as (1S,2R,5R,7R,8R,9R)-2- ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6-dioxo-3,15-dioxabicyclo[10.2.1]- pentadeca-11,13-dien-8-yl 3,4,6-trideoxy-3-(dimethylamino)-2-O-(phenylcarbonyl)- β-D-xylo-hexopyranoside (4) and (3R,5R,6R,7R,9R,11E,13S,14R)-14- ethyl-13-hydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxooxacyclotetradec- 11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-2-O-(phenylcarbonyl)-β-Dxylo- hexopyranoside (6) respectively by 2D NMR and single crystal X-ray diffraction.
Keywords: Ketolide synthesis; By-product isolation; Characterization; 2D NMR; Single crystal Xray structures Ketolide synthesis; By-product isolation; Characterization; 2D NMR; Single crystal Xray structures

Share and Cite

MDPI and ACS Style

MUNIGELA, N.; J., M.B.; YERRAMILLI, A.; SINGH, G.; REDDY, B.; TAKHI, M.; TATINI, L.K.; R., S.B.; VISHWESHWAR, P. Structural Studies of an Impurity Obtained During the Synthesis of Telithromycin Derivatives. Sci. Pharm. 2009, 77, 775-790. https://doi.org/10.3797/scipharm.0907-01

AMA Style

MUNIGELA N, J. MB, YERRAMILLI A, SINGH G, REDDY B, TAKHI M, TATINI LK, R. SB, VISHWESHWAR P. Structural Studies of an Impurity Obtained During the Synthesis of Telithromycin Derivatives. Scientia Pharmaceutica. 2009; 77(4):775-790. https://doi.org/10.3797/scipharm.0907-01

Chicago/Turabian Style

MUNIGELA, Nirmala, Moses BABU J., Anjaneyulu YERRAMILLI, Gurpreet SINGH, Bhaskar REDDY, Mohamed TAKHI, Lakshmi Kumar TATINI, Sreekanth BUKKAPATTANAM R., and Peddy VISHWESHWAR. 2009. "Structural Studies of an Impurity Obtained During the Synthesis of Telithromycin Derivatives" Scientia Pharmaceutica 77, no. 4: 775-790. https://doi.org/10.3797/scipharm.0907-01

APA Style

MUNIGELA, N., J., M. B., YERRAMILLI, A., SINGH, G., REDDY, B., TAKHI, M., TATINI, L. K., R., S. B., & VISHWESHWAR, P. (2009). Structural Studies of an Impurity Obtained During the Synthesis of Telithromycin Derivatives. Scientia Pharmaceutica, 77(4), 775-790. https://doi.org/10.3797/scipharm.0907-01

Article Metrics

Back to TopTop